Editas Medicine, Inc.
EDIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $185,707 | $96,344 | $104,920 |
| - Cash | $165,648 | $138,542 | $138,692 | $131,541 |
| + Debt | $13,564 | $77,805 | $31,133 | $35,032 |
| Enterprise Value | – | $124,970 | -$11,215 | $8,411 |
| Revenue | $7,543 | $3,578 | $4,658 | $30,604 |
| % Growth | 110.8% | -23.2% | -84.8% | – |
| Gross Profit | $7,543 | $3,578 | $4,658 | $30,604 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$21,997 | -$49,381 | -$71,955 | -$32,980 |
| % Margin | -291.6% | -1,380.1% | -1,544.8% | -107.8% |
| Net Income | -$25,117 | -$53,235 | -$76,088 | -$45,395 |
| % Margin | -333% | -1,487.8% | -1,633.5% | -148.3% |
| EPS Diluted | -0.28 | -0.63 | -0.92 | -0.55 |
| % Growth | 55.6% | 31.5% | -67.3% | – |
| Operating Cash Flow | -$30,843 | -$50,212 | -$47,799 | -$50,762 |
| Capital Expenditures | -$433 | $0 | -$114 | -$540 |
| Free Cash Flow | -$31,276 | -$50,212 | -$47,913 | -$51,302 |